| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.0M | +100.0% |
| R&D Expense | $168.1M | +20.8% |
| SG&A Expense | $53.3M | +79.2% |
| Operating Income | -$383.1M | -133.7% |
| Pre-tax Income | -$377.8M | -141.3% |
| Income Tax | -$79K | -118.4% |
| Net Income | -$377.7M | -140.6% |
| EPS (Basic) | -$8.44 | +29.0% |
| EPS (Diluted) | -$8.44 | +29.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $110.6M | -65.4% |
| Short-term Investments | $232.6M | +649.6% |
| Current Assets | $351.2M | -1.3% |
| Total Assets | $383.6M | +3.7% |
| Current Liabilities | $62.6M | +9.4% |
| Long-term Debt | $78.6M | — |
| Total Liabilities | $141.5M | +146.0% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$172.3M | -44.0% |
| Capital Expenditures | $18K | -86.3% |
| Investing Cash Flow | -$251.9M | -724.5% |
| Financing Cash Flow | $215.3M | -47.9% |
| Free Cash Flow | -$172.4M | -43.9% |
| $242.1M |
| -22.5% |